Andere Sprachen BioHarvest Sciences Inc.

Aktien

A2P3RM

CA09076J1084

BHSC

Markt geschlossen - Canadian Securities Exchange Andere Börsenplätze 21:49:23 10.05.2024			% 5 Tage	% 1. Jan.
0,24 ^CAD	+2,13 %		-7,69 %	+11,63 %

30.04.	BioHarvest Sciences Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
16.04.	BioHarvest Sciences Inc. kündigt neuen Campus für Botanical Synthesis CDMO und Erweiterung der Produktionskapazität an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 P.M. Eastern Time	01.05.
BioHarvest Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30.04.
BioHarvest Sciences Reports Strong Financial Performance for 2023, Eyes Nasdaq Listing	30.04.
BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results	30.04.
BioHarvest Sciences secures new state of the art 80,0000 square foot manufacturing facility	18.04.
BioHarvest Sciences Inc. Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity	16.04.
BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity	16.04.
BioHarvest Sciences adds key hires as company looks to ramp up CDMO Services Business Unit	27.03.
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables	21.03.
BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024	14.03.
BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit	13.03.
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on March 12-13, 2024	07.03.
BioHarvest Sciences to Host Corporate Update Discussing Launch of CDMO Business Unit on March 13 at 2:30 p.m. Eastern Time	29.02.
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules	26.02.
BioHarvest Sciences Inc. Announces Launch of New Contract Development and Manufacturing Organization Business Unit	26.02.
BioHarvest Sciences Inc. Signs First Contracts with Two Industrial Customers to Develop Complex Molecules Via Its Newly Launched Botanical Synthesis CDMO Business Unit	26.02.
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via Its Newly Launched Botanical Synthesis CDMO Business Unit	26.02.
BioHarvest Sciences Issues Clarification to February 15, 2024 News Release Announcing Engagement with IR Firm	20.02.
BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program	15.02.
BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference	12.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen BioHarvest Sciences Inc.

Aktien

A2P3RM

CA09076J1084

BHSC

Andere Sprachen

Filter